Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy.
暂无分享,去创建一个
[1] J. Waxman. Gonadotrophin hormone releasing analogues open new doors in cancer treatment. , 1987 .
[2] S. Lightman,et al. Response to O-TRP-6-LHRH (decapeptyl) in dvarian cancer , 1987 .
[3] U. Stenman,et al. Characterization of gonadotrophin receptors in a testosterone‐producing ovarian androblastoma. Case report , 1986, British journal of obstetrics and gynaecology.
[4] G. Emons,et al. GNRH-binding-sites in human epithelial ovarian carcinoma , 1986 .
[5] S. Lightman,et al. Advanced ovarian carcinoma: response to the agonist D-Trp-6-LHRH. , 1985, Cancer treatment reports.
[6] S. Lamberts,et al. Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist. , 1982, The Journal of clinical endocrinology and metabolism.
[7] H. Rajaniemi,et al. LH(hCG) Receptor in Benign and Malignant Tumors of Human Ovary , 1981, Acta obstetricia et gynecologica Scandinavica. Supplement.